The content on this page is currently unavailable.
Prescribing information for Lutathera®▼ (Lutetium [177Lu] oxodotreotide) can be found on this link.
AAA-Lu177-UK-1522 August 2022
This page is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here.
This portal is funded and owned by Novartis Pharmaceuticals UK Ltd and includes content approved by Novartis.
Adverse events reporting information can be found in the footer of this page.